- David Packham, honorary fellow1
- 1Materials Research Centre, University of Bath, Bath BA2 7AY, UK
- d.e.packham{at}bath.ac.uk
It is widely recognised that many prominent drug companies exert a nefarious effect on clinical research through abusing university sponsorship and confidentiality agreements in research contracts. Angell’s long editorial experience at the New England Journal of Medicine led her to comment “[i]t is simply no longer possible to believe much of the clinical research . . . published.”1
Heneghan …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
PDF
Social bookmarking